More than five decades after it was originally conceptualized as rescue therapy for patients
with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) …

Heart failure affects≈ 23 million people worldwide and continues to have a high mortality
despite advancements in modern pharmacotherapy and device therapy. HF is a complex …

Recent guidelines have been published providing detailed guidance on specific
echocardiographic diagnostic criteria for measurements of diastolic function, chamber …

A Prospective Study Identifying Predictive Factors of Cardia... : Hepatology A Prospective
Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular …

Purpose To determine the incidence of and risk factors for adverse cardiac events during
catecholamine vasopressor therapy in surgical intensive care unit patients with …

Background and Aims Transjugular intrahepatic portosystemic shunt (TIPS) is now a
standard for the treatment of portal hypertension–related complications. After the TIPS …

We investigated left ventricular diastolic dysfunction (LVDD) and its relationship with
circulatory function and prognosis in cirrhosis with portal hypertension and normal …

During the course of cirrhosis, there is a progressive deterioration of cardiac function
manifested by the disappearance of the hyperdynamic circulation due to a failure in heart …

Transjugular intrahepatic portosystemic shunt (TIPS) represents a very effective treatment of
complications of portal hypertension. Established indications to TIPS in cirrhotic patients …

Background Chronic congestive hepatopathy is known to cause hepatic fibrosis and portal
hypertension in patients post-Fontan operation for single ventricle palliation. The clinical …